Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems - Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord

被引:19
|
作者
Ongali, B
Buck, HD
Cloutier, F
Legault, F
Regoli, D
Lambert, C
Thibault, G
Couture, R
机构
[1] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Clin Res Inst, Montreal, PQ H3C 3J7, Canada
[4] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2003年 / 284卷 / 06期
关键词
bradykinin; B-1; receptor; B-2; hypertension;
D O I
10.1152/ajpheart.01113.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With the use of in vitro receptor autoradiography, this study aims at determining whether the higher level of kinin B-2 receptor density in the spinal cord of the spontaneously hypertensive rat (SHR) is secondary to arterial hypertension and whether chronic treatment with angiotensin I-converting enzyme inhibitors (ACEI) can regulate neuronal B-1 and B-2 receptors. SHR received, from the age of 4 wk, one of the two ACEI (lisinopril or zofenopril, 10 mg.kg(-1).day(-1)) or for comparison, the selective AT(1) antagonist (losartan, 20 mg.kg(-1).day(-1)) in their drinking water for a period of 4, 12, and 20 wk. Age-matched untreated SHR and Wistar-Kyoto rats (WKY) were used as controls. B-2 receptor binding sites in most laminae were higher in SHR than in WKY from the age of 8 to 24 wk. Whereas B-1 receptor binding sites were significantly present in young SHR and WKY, they were barely detectable in adult rats. ACEI (16 and 24 wk) and AT(1) antagonist (24 wk) enhanced the number of B-2 without changing B-1 receptor binding sites. However, at 8 wk the three treatments significantly increased B-1 and decreased B-2 receptors in lamina I. It is concluded that 1) the higher density of B-2 receptors in the spinal cord of SHR is not due to hypertension, 2) kinin receptors are regulated differently by ACEI in neuronal and vascular tissues, and 3) aging may have a profound impact on levels of B-1 and B-2 receptors in the rat spinal cord.
引用
收藏
页码:H1949 / H1958
页数:10
相关论文
共 29 条
  • [1] Kinins: Their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors.
    Adam, A
    Blais, C
    Loute, G
    NEPHROLOGIE, 2000, 21 (04): : 163 - 172
  • [2] CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ENDOTHELIAL FUNCTION OF RAT AORTA
    BERKENBOOM, G
    BREKINE, D
    UNGER, P
    GROSFILS, K
    STAROUKINE, M
    FONTAINE, J
    HYPERTENSION, 1995, 26 (05) : 738 - 743
  • [3] Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems -: Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure
    Blaukat, A
    Micke, P
    Kalatskaya, I
    Faussner, A
    Müller-Esterl, W
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (06): : H1909 - H1916
  • [4] Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems - Endopeptidases 3.4.24.15 and 24.16 in endothelial cells: potential role in vasoactive peptide metabolism
    Norman, MU
    Reeve, SB
    Dive, V
    Smith, AI
    Lew, RA
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (06): : H1978 - H1984
  • [5] Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition
    Berger, ED
    Bader, BD
    Ebert, C
    Risler, T
    Erley, CM
    JOURNAL OF HYPERTENSION, 2002, 20 (04) : 739 - 743
  • [6] Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure
    Witherow, FN
    Helmy, A
    Webb, DJ
    Fox, KAA
    Newby, DE
    CIRCULATION, 2001, 104 (18) : 2177 - 2181
  • [7] Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP
    Siragy, HM
    de Gasparo, M
    El-Kersh, M
    Carey, RM
    HYPERTENSION, 2001, 38 (02) : 183 - 186
  • [8] Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?
    Onuigbo, Macaulay A. C.
    Onuigbo, Nnonyelum T. C.
    CURRENT HYPERTENSION REVIEWS, 2012, 8 (04) : 256 - 266
  • [9] Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure
    Cruden, NLM
    Witherow, FN
    Webb, DJ
    Fox, KAA
    Newby, DE
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (06) : 1043 - 1048
  • [10] Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor
    Freise, Hendrik
    Palmes, Daniel
    Spiegel, Hans-Ullrich
    JOURNAL OF SURGICAL RESEARCH, 2006, 134 (02) : 231 - 237